Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain

Neuroscience Research

Volumn 34, Issue 1, 1999, Pages 21-29

  Lee, Ki Young ^a   Clark, Arthur W ^a   Rosales, Jesusa L ^a   Chapman, Kevin ^a   Fung, Tak ^a   Johnston, Randal N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alzheimer's disease; Cdk5; Cyclin dependent kinase; Neurofibrillary tangles; Paired helical filaments; Tau phosphorylation

Indexed keywords

PROTEIN KINASE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBELLUM CORTEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NEUROFIBRILLARY TANGLE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CEREBELLAR CORTEX; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PREFRONTAL CORTEX;

EID: 0032988741     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00026-7     Document Type: Article

References (56)

1. Baudier J., Cole D.R. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. Biol. Chem. 262:1987;17577-17583.
2. Baumann K., Mandelkow E., Biernat J., Piwnica-Worms H., Madelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases Cdk2 and Cdk5. FEBS Lett. 336:1993;417-424.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Drewes G., Lichtenberg-Kraag B., Doring F. et al. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
5. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol. 4:1996;139-148.
6. Goedert M., Spillantini M.G., Jakes R. et al. Molecular dissection of the paired helical filament. Neurobiol. Aging. 16:1995;326-334.
7. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer's disease brain. J. Neurochem. 61:1993;921-927.
8. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62:1994;803-806.
9. Graus F., Elkon K.B., Lloberes P. et al. Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol. (Scand.). 75:1987;249-252.
10. Gultekin S.H., Dalmau J., Graus Y., Posner J.B., Rosenblum M.K. Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors: a study of 112 central neuroepithelial neoplasms. Am. J. Surg. Pathol. 22:1998;195-200.
11. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett. 147:1992;58-62.
12. Hellmich M.R., Pant H.C., Wada E., Battery J.F. Neuronal Cdc2-like kinase: a Cdc2-related protein kinase with predominantly neuronal expression. Proc. Natl. Acad. Sci. USA. 90:1992;10867-10871.
13. Hyman B.T., Trojanowski J.Q. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1977;1095-1097.
14. Illenberger S., Zheng-Fischerhofer Q., Preuss U. et al. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell. 9:1998;1495-1512.
15. Iqbal K., Grundke-Iqbal I. Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau and causes the disruption of microtubules. Neurobiol. Aging. 16:1995;375-379.
16. Ishiguro K., Kobayashi S., Omori A. et al. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of Cdk5 in bovine brain. FEBS Lett. 342:1994;203-208.
17. Kidd M. Paired helical filaments in electronic microscopy of Alzheimer's disease. Nature. 197:1963;192-193.
18. Ladner C.J., Czech J., Maurice J., Lorens S.A., Lee J.M. Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J. Neuropathol. Exp. Neurol. 55:1996;924-931.
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
20. Ledesma M.D., Correas I., Avila J., Diaz-Nido J. Implication of brain Cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308:1992;218-224.
21. Lee K.-Y., Helbing C.C., Choi K.-S., Johnston R.N., Wang J.H. Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J. Biol. Chem. 272:1997;5622-5626.
22. Lee K.-Y., Johnston R.N. Neurofilaments are part of the high molecular weight complex containing neuronal Cdc2-like kinase (Nclk). Brain Res. 773:1997;197-202.
23. Lee K.-Y., Qi Z., Zu Y.P., Wang J.H. Neuronal Cdc2-like kinases: Neuron-specific forms of Cdk5. Int. J. Biochem. Cell. Biol. 29:1997;951-958.
24. Lee K.-Y., Rosales J.L., Tang D., Wang J.H. Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain. J. Biol. Chem. 271:1996;1538-1543.
25. Lew J., Beaudette K., Litwin C.M.E., Wang J.H. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 267:1992;13383-13390.
26. Lew J., Huang Q.Q., Qi Z., Winkfein R.J., Aebersold R., Hunt T., Wang J.H. A brain-specific activator of cyclin-dependent kinase 5. Nature. 371:1994;423-426.
27. Lew J., Wang J.H. Neuronal Cdc2-like kinase. Trends Biol. Sci. 20:1995;33-37.
28. Lew J., Winkfein R.J., Paudel H.K., Wang J.H. Brain proline-directed protein kinase as a neurofilament kinase which displays high sequence homology to p34cdc2. J. Biol. Chem. 267:1992;25922-25926.
29. Liu W., Williams R.T., Hall F.L., Dickson D.W., Yen S.H. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am. J. Pathol. 146:1995;228-238.
30. Mandelkow E.M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J.R., Mandelkow E. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314:1992;315-321.
31. Matsuo E.S., Shin R.-W., Billingsley M.L., Van deVoorde A., O'connor M., Trojanowski J.Q., Lee V.M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
32. Meyerson M., Enders G.H., Wu C.-L. et al. A family of human Cdc2-related protein kinases. EMBO J. 11:1992;2909-2917.
33. Mizutani T., Amano N., Sasaki H. et al. Senile dementia of Alzheimer type characterized by laminar neuronal loss exclusively in the hippocampus, parahippocampus, and medial occipitotemporal cortex. Acta Neuropathol. 80:1990;575-580.
34. Morishima-Kawashima M., Hasegawa M., Takio K. et al. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270:1995;823-829.
35. Morishima-Kawashima M., Hasegawa M., Takio K. et al. Hyperphosphorylation of tau in PHF. Neurobiol. Aging. 16:1995;365-380.
36. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F.M., Tsai L.-H. The Cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10:1996;816-825.
37. Nikolic M., Chou M.M., Lu W., Mayer B.J., Tsai L.-H. The Cdk5/p35 is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 195:1998;194-198.
38. Paudel H.K. Phosphorylation by neuronal Cdc2-like protein kinase promotes dimerization of tau protein in vitro. J. Biol. Chem. 272:1997;28328-28334.
39. Paudel H.K., Lew J., Ali Z., Wang J.H Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's. J. Biol. Chem. 268:1993;23512-23518.
40. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R. Accumulation of cyclin-dependent kinase 5 (Cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797:1998;267-277.
41. Pei J.J., Tanaka T., Tung Y.C., Braak E., Iqbal K., Grundke-Iqbal I. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56:1997;70-78.
42. Qi Z., Tang D., Zhu X., Fugita D.J., Wang J.H. Association of neurofilament proteins with neuronal Cdk5 activator. J. Biol. Chem. 273:1998;2329-2335.
43. Roder H.M., Eden P.A., Ingram V.M. Brain protein kinase PK40erk converts tau into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Comm. 193:1993;639-647.
44. Seubert P., Mawal-Dewan M., Barbour R. et al. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270:1996;18917-18922.
45. Shetty K.T., Kaech S., Link W.T. et al. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J. Neurochem. 64:1995;1988-1995.
46. Singh T.J., Haque N., Grundke-Iqbal I., Iqbal K. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline dependent protein kinases and GSK-3. FEBS Lett. 358:1995;267-272.
47. Sun D., Leung C.L., Liem R.K.H. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 271:1996;14245-14251.
48. Tang D., Yeung J., Lee K.-Y. et al. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J. Biol. Chem. 270:1996;26897-26903.
49. Terry R.D., Hansen L.A., DeTeresa R., Davies P., Tobias H., Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 46:1987;262-268.
50. Trojanowski J.Q., Lee V.M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 9:1995;1570-1576.
51. Tsai L.-H., Delalle I., Caviness V.S., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 371:1994;419-423.
52. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132:1996;413-425.
53. Wisniewski H.M., Narang H.K., Terry R.D. Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 27:1976;173-181.
54. Xiao J., Perry G., Troncoso J., Monteiro M.J. Alpha calcium calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;954-963.
55. Xiong W., Pestell R., Rosner M.R. Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol. Cell. Biol. 17:1997;6585-6597.
56. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C.A., Imahori K. Preferential labelling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. 92:1996;232-241.